Loading…

Hemophilia Inhibitor Research

Hemophilia Inhibitor Research Project
Hemophilia Inhibitor Research Collection

Hemophilia Inhibitor Research

Release Date: 5/7/19

View Scope

Protocol Name Protocol Id Collection
Add to My Toolkit Adherence to Episodic Clotting Factor Treatment Regimens in Hemophilia 911602 Hemophilia Inhibitor Research
Add to My Toolkit Adherence to Prophylactic Clotting Factor Treatment Regimens in Hemophilia 911601 Hemophilia Inhibitor Research
Add to My Toolkit Counts of Acute Bleeds in Hemophilia 910101 Hemophilia Inhibitor Research
Add to My Toolkit Determination of Factor IX Inhibitors: Bethesda Assay with Nijmegen Modification Using Chromogenic Substrate Assay 910401 Hemophilia Inhibitor Research
Add to My Toolkit Determination of Factor IX Inhibitors: Bethesda Assay with or without Nijmegen Modification Using One-Stage Clotting Factor Assay 910402 Hemophilia Inhibitor Research
Add to My Toolkit Determination of Factor VIII Inhibitors: Bethesda Assay with Nijmegen Modification Using Chromogenic Substrate Assay 910501 Hemophilia Inhibitor Research
Add to My Toolkit Determination of Factor VIII Inhibitors: Bethesda Assay with Nijmegen Modification Using One-Stage Clotting Factor Assay 910502 Hemophilia Inhibitor Research
Add to My Toolkit Disease-specific Health-related Quality of Life in Hemophilia 910701 Hemophilia Inhibitor Research
Add to My Toolkit Emicizumab Therapy: Determination of Factor VIII Inhibitors Using the Bethesda Assay with Nijmegen Modification: Chromogenic Substrate Assay with Bovine Reagents 911301 Hemophilia Inhibitor Research
Add to My Toolkit Emicizumab Therapy: Individual Pharmacokinetic Study of Extended Half-life Factor VIII Products: Chromogenic Substrate Assay with Bovine Reagents 911402 Hemophilia Inhibitor Research
Add to My Toolkit Emicizumab Therapy: Individual Pharmacokinetic Study of Standard Half-life Factor VIII Products: Chromogenic Substrate Assay with Bovine Reagents 911401 Hemophilia Inhibitor Research
Add to My Toolkit Emicizumab Therapy: Population-based Pharmacokinetic Study of Extended Half-life Factor VIII Products: Chromogenic Substrate Assay with Bovine Reagents 911502 Hemophilia Inhibitor Research
Add to My Toolkit Emicizumab Therapy: Population-based Pharmacokinetic Study of Standard Half-life Factor VIII Products: Chromogenic Substrate Assay with Bovine Reagents 911501 Hemophilia Inhibitor Research
Add to My Toolkit Factor IX Activity in Plasma Using the Chromogenic Substrate Assay 910201 Hemophilia Inhibitor Research
Add to My Toolkit Factor IX Activity in Plasma Using the One-Stage Clotting Factor Assay 910202 Hemophilia Inhibitor Research
Add to My Toolkit Factor VIII Activity in Plasma Using the Chromogenic Substrate Assay 910301 Hemophilia Inhibitor Research
Add to My Toolkit Factor VIII Activity in Plasma Using the One-Stage Clotting Factor Assay 910302 Hemophilia Inhibitor Research
Add to My Toolkit Hemophilia Joint Health Score 911701 Hemophilia Inhibitor Research
Add to My Toolkit Hemophilia-specific Functional Ability - Adult 910802 Hemophilia Inhibitor Research
Add to My Toolkit Hemophilia-specific Functional Ability - Child 910801 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study Using Chromogenic Assay - Extended Half-life Factor IX Products 910904 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study Using Chromogenic Assay - Standard Half-life Factor IX Products 910903 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study Using Chromogenic Substrate Assay - Extended Half-life Factor VIII Products 911104 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study Using Chromogenic Substrate Assay - Standard Half-life Factor VIII Products 911103 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study using One-stage Clotting Factor Assay - Extended Half-life Factor IX Products 910902 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study Using One-stage Clotting Factor Assay - Extended Half-life Factor VIII Products 911102 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study using One-stage Clotting Factor Assay - Standard Half-life Factor IX Products 910901 Hemophilia Inhibitor Research
Add to My Toolkit Individual Pharmacokinetic Study Using One-stage Clotting Factor Assay - Standard Half-life Factor VIII Products 911101 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using Chromogenic Substrate Assay - Extended Half-life Factor IX Products 911004 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using Chromogenic Substrate Assay - Extended Half-life Factor VIII Products 911204 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using Chromogenic Substrate Assay - Standard Half-life Factor IX Products 911003 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using Chromogenic Substrate Assay - Standard Half-life Factor VIII Products 911203 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using One-stage Clotting Factor Assay - Extended Half-life Factor IX Products 911002 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using One-stage Clotting Factor Assay - Extended Half-life Factor VIII Products 911202 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using One-stage Clotting Factor Assay - Standard Half-life Factor IX Products 911001 Hemophilia Inhibitor Research
Add to My Toolkit Population-based Pharmacokinetic Study Using One-stage Clotting Factor Assay - Standard Half-life Factor VIII Products 911201 Hemophilia Inhibitor Research
Add to My Toolkit School and Work Attendance - Adult 910602 Hemophilia Inhibitor Research
Add to My Toolkit School Attendance - Child 910601 Hemophilia Inhibitor Research